Daiwa Securities Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
13,378
+10,234
| +326% | +$1.55M | 0.01% | 615 |
|
|
2025
Q1 | $473K | Sell |
3,144
-3,676
| -54% | -$553K | ﹤0.01% | 835 |
|
|
2024
Q4 | $1.26M | Buy |
6,820
+465
| +7% | +$85.8K | 0.01% | 685 |
|
|
2024
Q3 | $1.25M | Buy |
6,355
+710
| +13% | +$140K | 0.01% | 689 |
|
|
2024
Q2 | $1.17M | Buy |
5,645
+582
| +11% | +$120K | 0.01% | 675 |
|
|
2024
Q1 | $1.37M | Buy |
5,063
+514
| +11% | +$139K | 0.01% | 647 |
|
|
2023
Q4 | $1.08M | Buy |
4,549
+265
| +6% | +$62.6K | 0.01% | 681 |
|
|
2023
Q3 | $840K | Buy |
4,284
+266
| +7% | +$52.2K | 0.01% | 716 |
|
|
2023
Q2 | $845K | Buy |
4,018
+211
| +6% | +$44.4K | 0.01% | 699 |
|
|
2023
Q1 | $768K | Buy |
3,807
+200
| +6% | +$40.3K | 0.01% | 715 |
|
|
2022
Q4 | $786K | Buy |
3,607
+200
| +6% | +$43.6K | 0.01% | 705 |
|
|
2022
Q3 | $670K | Buy |
3,407
+178
| +6% | +$35K | 0.01% | 735 |
|
|
2022
Q2 | $691K | Buy |
3,229
+28
| +0.9% | +$5.99K | 0.01% | 752 |
|
|
2022
Q1 | $909K | Buy |
3,201
+192
| +6% | +$54.5K | 0.01% | 725 |
|
|
2021
Q4 | $1.13M | Buy |
3,009
+174
| +6% | +$65.6K | 0.01% | 672 |
|
|
2021
Q3 | $1.17M | Buy |
2,835
+56
| +2% | +$23.1K | 0.01% | 633 |
|
|
2021
Q2 | $1.03M | Buy |
+2,779
| New | +$1.03M | 0.01% | 631 |
|